Plasma activated clotting time as an indicator of dangerous hypocoagulability in warfarin-treated trauma patients: A preliminary study

Surgery Today

Volumn 28, Issue 8, 1998, Pages 834-838

  Terai, Chikanori ^a   Saitoh, Daizoh ^a   Okamoto, Ken ^b   Kawakami, Masato ^a   Magario, Naoki ^b  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b EISAI CO LTD   (Japan)

Author keywords

Activated clotting time; Hypocoagulability; Injury; Warfarin

Indexed keywords

ANTICOAGULANT AGENT; CALCIUM CHLORIDE; WARFARIN;

ANTICOAGULANT THERAPY; ARTICLE; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TIME; CONTROLLED STUDY; HEMATOLOGICAL PARAMETERS; HUMAN; HYPERCOAGULABILITY; PATIENT MONITORING; PLASMA; TRAUMATOLOGY;

ANTICOAGULANTS; BLOOD COAGULATION; EMERGENCY TREATMENT; HUMANS; PROGNOSIS; SENSITIVITY AND SPECIFICITY; WARFARIN; WOUNDS AND INJURIES;

EID: 0031859202     PISSN: 09411291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005950050236     Document Type: Article

References (27)

1. Sullivan JM, Harken DE, Gorlin R (1971) Pharmacologic control of thromboembolic complications of cardiac valve replacement. N Engl J Med 284:1391-1394
2. Van Vroonhoven TJMV, Van Zijl J, Muller H (1974) Low dose subcutaneous heparin versus oral anticoagulant in the prevention of postoperative deep venous thrombosis. Lancet 1:375-378
3. Rose SD (1979) Prophylaxis of thromboembolic disease. Med Clin North Am 63:1205-1224
4. Szekely P (1964) Systemic embolism and anticoagulant prophylaxis in rheumatic heart disease. Br Med J 1:1209-1212
5. Whisnant JP, Matsumoto N, Elveback LR (1973) The effect of anticoagulant therapy on the prognosis of patients with transient cerebral ischemic attacks in a community. Mayo Clin Proc 48:844-848
6. Hodin E, Dass T (1969) Spontaneous retroperitoneal hemorrhage complicating anticoagulant therapy. Ann Surg 170:848-851
7. Hirsh JH (1991) Oral anticoagulant drugs. N Engl J Med 324:1865-1875
8. Owren PA (1959) Thrombotest: a new method for controlling anticoagulant treatment. Lancet ii:754-758
9. Murakami S, Muratani H, Kikuchi T, Fugimoto S, Hayashi T, Inai S, Imaoka S (1983) Evaluation of prothrombin time and thrombotest and hepaplastin test for the control of oral anticoagulant therapy (in Japanese). Jpn J Clin Pathol 31:210-214
10. Lucas FV, Duncan A, Jay R, Coleman R, Craft P, Chan B, Winfrey L, Mungall DR, Hirsh J (1987) A novel whole blood capillary technic for measuring the prothrombin time. Am J Clin Pathol 88:442-446
11. Kaatz SK, While RH, Hill J, Mascha E, Humphries JE, Becker DM (1995) Accuracy of laboratory and portable monitor international normalized ratio determinations: comparison with a criterion standard. Arch Intern Med 155:1861-1867
12. Hattersley PG (1966) Activated coagulation time of whole blood. JAMA 196:436-440
13. Hsposito RA, Culliford AT, Colvin SB, Thomas SJ, Luckner H, Spencer FC (1983) The role of the activated clotting time in heparin administration and neutralization for cardiopulmonary bypass. J Thorac Cardiovasc Surg 85:174-185
14. Cohen JA (1984) Activated coagulation time method for control of heparin is reliable during cardiopulmonary bypass. Anesthesiology 60:121-124
15. Ogilby JD, Kopelman HA, Klein LW, Agarwal JB (1988) Adequate heparinization during PTCA: assessment using activated clotting time. JACC 11:237A
16. Ferguson JJ III (1995) Conventional antithrombotic approaches. Am Heart J 130:651-657
17. Scott JA, Berenstein AB, Blumenthal RN (1986) Use of the activated coagulation time as a measure of anticoagulation during interventional procedures. Radiology 158:849-850
18. Krummel TM, Greenfield LJ, Kirkpatrick BV, Mueller DG, Ormazabal M, Salzberg A (1982) Clinical use of an extracorponeal membrane oxygenator in neonatal pulmonary failure. J Pediatr Surg 17:525-531
19. Mault JR, Dechert RE, Lees P, Swartz RD, Port FK, Bartlett RH (1987) Continuous arteriovenous filtration: an effective treatment for surgical acute renal failure. Surgery 101:478-484
20. Congdon JE, Kardinal CG, Wallin JD (1973) Monitoring heparin therapy in hemodialysis: a report on the activated whole blood coagulation time tests, JAMA 226:1529-1533
21. Conti S, Daschbach M, Blaisdell FW (1982) A comparison of high-dose versus conventional-dose heparin therapy for deep vein thrombosis. Surgery 92:972-980
22. Stanley TE III, Reves JG (1994) Cardiovascular monitoring. In: Miller RD (ed) Anesthesia, Vol. 1. Churchill Livingstone, New York, pp 1161-1228
23. Poller L (1987) Laboratory control for oral anticoagulants. Br Med J 294:1184
24. Brockmans AW, Loeliger EA (1982) Therapeutic control of anticoagulant treatment. Br Med J 284:1330-1331
25. O'Mara K, Marichak V (1983) Trauma and oral anticoagulant. Ann Emerg Med 12:700-703
26. O'Reilly RA, Aggeler PM (1968) Studies on coumarin anticoagulant drugs: initiation of warfarin therapy without a loading dose. Circulation 38:169-177
27. Rutledge R, Sheldon GF (1988) Bleeding and coagulation problems. In: Mattox KL, Moore EE, Feliciano DV (eds) Trauma. Appleton and Lange, Norwalk, CT, pp 809-819